Compare AbCellera Biologics Inc (ABCL) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Zillow Group Inc Class C — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while Zillow Group Inc Class C trades at $34.1 (market cap $7.68B). The key difference: Zillow Group Inc Class C is far larger — about 2.6× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals.
| ABCL | Z | |
|---|---|---|
Market Cap | $2.99B | $7.68B |
Sector | Health | Media |
52-Week High | $9.76 | $90.35 |
52-Week Low | $2.78 | $29.41 |
Enterprise Value | $2.58B | $7.56B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
